Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Accelerated Phase × olaparib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Ovarian Neoplasms 31 Prostatic Neoplasms 18 Fallopian Tube Neoplasms 16 Triple Negative Breast Neoplasms 15 Neoplasm Metastasis 11 Neoplasms 9 Pancreatic Neoplasms 8 Endometrial Neoplasms 8 Small Cell Lung Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 5 Sarcoma 5 Glioma 5 Lung Neoplasms 4 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Metastatic Castration-resistant Prostate Cancer 3 Lymphoma, Non-Hodgkin 3 Cholangiocarcinoma 3 Carcinoma, Ovarian Epithelial 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Pathologic Complete Response 2 Osteosarcoma 2

Interventions

Cyclophosphamide 8 fludarabine phosphate 5 Methotrexate 5 ponatinib 4 Whole-Body Irradiation 4 merphos 3 Tacrolimus 3 Rituximab 3 Peripheral Blood Stem Cell Transplantation 3 Mycophenolic Acid 3 CT-P10 3 Busulfan 3 letermovir 2 Vincristine 2 Melphalan 2 Cytarabine 2 Cyclosporine 2 venetoclax 1 prednylidene 1 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 deltacortene 1 bosutinib 1 blinatumomab 1 auricularum 1 Vorinostat 1 Valganciclovir 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡